We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-10.00 | -0.50% | 2,002.00 | 2,006.00 | 2,008.00 | 2,024.00 | 1,994.00 | 2,014.00 | 178,227 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 23.10 | 4.43B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2021 08:56 | But has bounced back. | robertball | |
05/8/2021 08:30 | Down last two days before figures tomorrow, always someone knows more than us, perhaps disappointing tomorrow, shareprice talks. | montyhedge | |
02/8/2021 15:26 | In line with analyst expectations would be good, analyst always expect to much. | montyhedge | |
02/8/2021 15:24 | *re rating | robertball | |
02/8/2021 14:27 | That'll do me. As there will be a retracting.This one is not doing too badly as a defensive | robertball | |
02/8/2021 14:25 | Figures this Friday, 6th August, expected to be in line with analyst forecast. | montyhedge | |
30/7/2021 14:48 | Interesting top two shares to buy in August, Hikma one of them. | montyhedge | |
27/7/2021 11:40 | I know tuck away and not really for trading, seems to double every four years, but it must be on someone's takeover radar. Takeover would have to be around 50 pounds a share, to get this superb company. | montyhedge | |
27/7/2021 09:15 | Very strong underlying buyers, market makers try to mark down below 2600p but bounces right back. | montyhedge | |
25/7/2021 18:22 | Goood results from lonza on Friday (Swiss listed' | robertball | |
22/7/2021 13:40 | Out of all pharmaceuticals quoted on the Lse markets, Hikma on fundamentals look the best value.Perhaps one reason, Barclays upped their target to 2800p yesterday.It's not a trading stock but a Buffett style, buy and leave bottom draw, seems to double every 4 years. | montyhedge | |
22/7/2021 07:29 | It's a defensive. | robertball | |
21/7/2021 19:26 | Strange, Barclays have Hikma today report, target 2800p, shares fall.https://www.ame | montyhedge | |
20/7/2021 16:19 | Pound weak last few days against the dollar that's always good for Hikma profits and dividends. | montyhedge | |
20/7/2021 10:56 | Another big buy just gone through, ok who's stake building. | montyhedge | |
20/7/2021 09:24 | As a defensive stick it's doing quite well. Fundamentals coming to the fore | robertball | |
20/7/2021 09:05 | For a pharma stock forecast p.e around 16 it's cheap anyway, a bidder would have to pay of p.e30. So double this shareprice. | montyhedge | |
19/7/2021 09:20 | Looks like a large trade earlier, mm thought pull the price down, fill that order make a turn, unlucky boys.This is taking off. | montyhedge | |
19/7/2021 08:28 | Sitting duck for a bid. They would have to pay 4500p to get them. | montyhedge | |
19/7/2021 08:26 | This will be 3000p in my opinion on fundamentals, 4500p if bid for. | montyhedge | |
16/7/2021 12:48 | Price action has been a. Good. Higher lows and lower dips during mot sell off. Results soonish | robertball | |
16/7/2021 08:47 | Only that this is one of my better performing shares in recent times. Long may it continue! Suet | suetballs | |
14/7/2021 17:07 | Any comment on price action over past 2 days??? | robertball | |
09/7/2021 16:04 | Hmm. So this is propelling interest.. | robertball | |
09/7/2021 15:50 | Surely Hikma cannot let it's partner Vectura be taken over by Philip Morris? | jimboyce |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions